Načítá se...
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
Narcolepsy is a neurological disease that affects 1 in 2,000 individuals and is characterized by excessive daytime sleepiness (EDS). In 60–70% of individuals with narcolepsy, it is also characterized by cataplexy or a sudden loss of muscle tone that is triggered by positive or negative emotions. Nar...
Uloženo v:
| Vydáno v: | Nat Sci Sleep |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414617/ https://ncbi.nlm.nih.gov/pubmed/28490912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NSS.S103462 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|